Latest Australian Regulatory Environment News

The Treasurer has expressed preliminary concerns that Cosette Pharmaceuticals’ proposed acquisition of Mayne Pharma could harm Australia’s economy, citing plans to close a key Adelaide manufacturing site. Mayne Pharma disputes these claims and urges a resolution before the scheme deadline.

Merchant House International Limited has voluntarily suspended trading on the ASX following the resignation of its only Australian director, Ian Burton. The suspension is expected to last until a new Australian director is appointed, anticipated by late February.